SUVRETTA CAPITAL MANAGEMENT LLC 13D and 13G filings for Benitec Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-04-18 4:16 pm Sale |
2022-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT LLC | 177,660 9.990% |
-194,617 (-52.28%) |
Filing |
| 2023-02-13 12:25 pm Purchase |
2022-12-31 | 13G | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT LLC | 372,276 9.990% |
327,041 (+722.98%) |
Filing |
| 2021-05-07 4:46 pm Purchase |
2021-04-28 | 13G | Benitec Biopharma Inc. BNTC |
SUVRETTA CAPITAL MANAGEMENT LLC | 45,235 9.800% |
45,235 (New Position) |
Filing |